A. Grein

1.2k total citations · 1 hit paper
22 papers, 850 citations indexed

About

A. Grein is a scholar working on Pharmacology, Molecular Biology and Plant Science. According to data from OpenAlex, A. Grein has authored 22 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 7 papers in Molecular Biology and 5 papers in Plant Science. Recurrent topics in A. Grein's work include Microbial Natural Products and Biosynthesis (16 papers), Chemical Synthesis and Analysis (3 papers) and Infectious Diseases and Mycology (3 papers). A. Grein is often cited by papers focused on Microbial Natural Products and Biosynthesis (16 papers), Chemical Synthesis and Analysis (3 papers) and Infectious Diseases and Mycology (3 papers). A. Grein collaborates with scholars based in Italy, Switzerland and Germany. A. Grein's co-authors include C. Spalla, Giuseppe Cassinelli, Federico Arcamone, P. Orezzi, Samuel P. Meyers, Anna Maria Casazza, A Sanfilippo, Graziella Pratesi, Aurelio Di Marco and Nicoletta Crespi-Perellino and has published in prestigious journals such as Journal of Bacteriology, Cellular and Molecular Life Sciences and Biotechnology and Bioengineering.

In The Last Decade

A. Grein

20 papers receiving 773 citations

Hit Papers

Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibio... 1969 2026 1988 2007 1969 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Grein Italy 12 369 299 209 197 155 22 850
C. Spalla Italy 13 366 1.0× 252 0.8× 198 0.9× 215 1.1× 150 1.0× 32 898
Taiji Inui Japan 16 472 1.3× 258 0.9× 192 0.9× 269 1.4× 82 0.5× 47 864
Bijoy K. Bhuyan United States 14 602 1.6× 95 0.3× 334 1.6× 108 0.5× 24 0.2× 31 1.2k
Frank G. Pilkiewicz United States 15 259 0.7× 36 0.1× 152 0.7× 197 1.0× 85 0.5× 18 834
Nicolas Inguimbert France 19 524 1.4× 151 0.5× 140 0.7× 299 1.5× 109 0.7× 64 904
Tsau-Yen Lin United States 17 535 1.4× 29 0.1× 145 0.7× 155 0.8× 80 0.5× 24 963
Seizi Kurozumi Japan 19 355 1.0× 260 0.9× 70 0.3× 563 2.9× 20 0.1× 87 1.1k
Aneta Koceva‐Chyła Poland 19 378 1.0× 87 0.3× 271 1.3× 257 1.3× 81 0.5× 45 963
Christian Birr Germany 17 730 2.0× 53 0.2× 94 0.4× 258 1.3× 53 0.3× 58 1.1k
H Ekimoto Japan 19 759 2.1× 125 0.4× 196 0.9× 380 1.9× 13 0.1× 47 1.4k

Countries citing papers authored by A. Grein

Since Specialization
Citations

This map shows the geographic impact of A. Grein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Grein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Grein more than expected).

Fields of papers citing papers by A. Grein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Grein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Grein. The network helps show where A. Grein may publish in the future.

Co-authorship network of co-authors of A. Grein

This figure shows the co-authorship network connecting the top 25 collaborators of A. Grein. A scholar is included among the top collaborators of A. Grein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Grein. A. Grein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grein, A., et al.. (2003). [Use of Bacto media and proposal of a Czapek substratum with casein as a standard for culture of Actinomyces].. PubMed. 5(4). 296–8.
2.
Arcamone, Federico, et al.. (2000). Adriamycin, 14-Hydroxydaunomycin, a new antitumor antibiotic fromS. peucetius var.caesius. Biotechnology and Bioengineering. 67(6). 704–713. 54 indexed citations
3.
Cassinelli, Giuseppe, et al.. (1990). New biosynthetic anthracyclines related to barminomycins incorporating barbiturates in their moiety.. The Journal of Antibiotics. 43(1). 19–28. 4 indexed citations
4.
Grein, A.. (1987). Antitumor Anthracyclines Produced by Streptomyces peucetius. Advances in applied microbiology. 32. 203–214. 33 indexed citations
5.
Cassinelli, Giuseppe, et al.. (1987). A new class of biosynthetic anthracyclines: Anthracyclinone glucuronides.. The Journal of Antibiotics. 40(7). 1071–1074. 4 indexed citations
6.
Cassinelli, Giuseppe, et al.. (1985). 13-Deoxycarminomycin, a New Biosynthetic Anthracycline. Journal of Natural Products. 48(3). 435–439. 13 indexed citations
7.
Crespi-Perellino, Nicoletta, et al.. (1982). Biosynthetic relationships among daunorubicin, doxorubicin and 13-dihydrodaunorubicin inStreptomyces peucetius. Cellular and Molecular Life Sciences. 38(12). 1455–1456. 11 indexed citations
8.
Cassinelli, Giuseppe, Federico Arcamone, A. Grein, et al.. (1982). New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.. The Journal of Antibiotics. 35(2). 176–183. 32 indexed citations
9.
Colombo, Arnaldo Lopes, Nicoletta Crespi-Perellino, A. Grein, A. Minghetti, & C. Spalla. (1981). Metabolic and genetic aspects of the relationship between growth and tetracycline production in Streptomyces aureofaciens. Biotechnology Letters. 3(2). 71–76. 11 indexed citations
10.
Grein, A., et al.. (1980). New anthracycline glycosides from Micromonospora. I. Description of the producing strain.. The Journal of Antibiotics. 33(12). 1462–1467. 9 indexed citations
11.
Grein, A., Paolo Masi, Luigi Rossi Bernardi, et al.. (1978). Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.. The Journal of Antibiotics. 31(3). 178–184. 26 indexed citations
12.
Grein, A., et al.. (1974). Axenomycins, new anthelmintic, antiprotozoal and antifungal antibiotics, produced by Streptomyces lisandri nov. sp.. Archives of Microbiology. 98(1). 289–299. 8 indexed citations
13.
Grein, A., et al.. (1970). Streptomyces mediolani (ARCAMONEet al.) emend. BIANCHIet al. and its production of carotenoids. Zeitschrift für allgemeine Mikrobiologie. 10(4). 237–244. 1 indexed citations
14.
Cassinelli, Giuseppe, et al.. (1970). Thaimycins, new anthelmintic and antiprotozoal antibiotics produced by Streptomyces michiganensis var. amylolyticus var. nova. Archives of Microbiology. 70(3). 197–210. 12 indexed citations
15.
Grein, A., et al.. (1970). Streptomyces mediolani (ARCAMONEet al.)emend. BIANCHIet al. and its production of carotenoids. Journal of Basic Microbiology. 10(4). 237–244. 3 indexed citations
16.
Arcamone, F, et al.. (1969). New carotenoids fromStreptomyces mediolani n. sp.. Cellular and Molecular Life Sciences. 25(3). 241–242. 19 indexed citations
17.
Arcamone, Federico, et al.. (1969). Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius. Biotechnology and Bioengineering. 11(6). 1101–1110. 477 indexed citations breakdown →
18.
Cassinelli, Giuseppe, et al.. (1967). New antibiotics produced by streptoverticillium orinoci, n. sp.. Archives of Microbiology. 55(4). 358–368. 34 indexed citations
19.
Grein, A., et al.. (1955). Vergleichemde Untersuchungen zur Systematik der Streptomyceten. Die Naturwissenschaften. 42(2). 52–52. 5 indexed citations
20.
Spalla, C., et al.. (1954). The classification of the actinomyces species (= Streptomyces). Archives of Microbiology. 20(4). 347–357. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026